Gene Query: COL4A5

Dataset Description Geneva Score
Regulation of Lipids is Central to Replicative Senescence 158.6
RNA-seq of human fibroblasts after irradiation 118.31
Differential analysis of gene regulation at transcript resolution by RNA-Seq 85.65
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 85.65
Differential expression of genes in AD169-infected MRC5. 85.13
A549 cells and MSR-A549 cells 78.11
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 78.11
RNA-seq of shEZH2 cells 69.48
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 67.94
64.0
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 60.71
GATA3-mediated chromatin reprogramming in breast cancer cells 56.64
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 56.47
Control of prostate tumour growth by the long non-coding RNA GHSROS 55.8
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 54.95
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 52.8
RNA-sequencing of formalin fixed human primary melanoma tissue 52.54
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 49.48
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 49.33
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 49.33
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 49.28
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 48.64
AR-independent prostate cancer is sustained through FGF signaling 48.59
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 46.17
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 45.46
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 45.46
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 45.46
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 45.46
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 45.27
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 44.95
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 43.8
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 43.8
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 43.62
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 43.62
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 43.28
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 43.12
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 43.12
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 42.67
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 41.88
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 41.46
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 40.81
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 40.1
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 40.07
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 40.07
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 39.76
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 38.14
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 37.94
RNA Seq of HMVEC under hypoxia 36.92
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 36.92
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 36.07
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 35.96
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 34.82
Nucleoporin-mediated regulation of cell identity genes 34.34
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 32.56
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 32.27
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 30.94
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 30.5
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 29.16
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 28.89
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 28.66
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 28.48
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 28.47
Fbxo32 mediated gene expression program underlies EMT and metastasis 28.0
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 27.93
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 27.88
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 27.78
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 27.62
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 27.32
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 27.32
BAF controls genome accessibility 27.0
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 26.74
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 26.59
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 26.5
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 26.39
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 25.91
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 25.58
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 25.45
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 25.39
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 25.15
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 25.1
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 25.0
Transcriptome analysis of U87 cells upon LINC00152 knockdown 24.91
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 24.65
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 24.64
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 24.49
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 24.34
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 24.26
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 24.1
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 23.91
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 23.84
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 23.53
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 23.22
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 23.19
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 23.18
NR2F2 study 23.18
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 23.13
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp1] 23.01
AMPK signaling for naïve pluripotency [Hs] 22.95
AMPK signaling for naïve pluripotency 22.95
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 22.9
Overexpression and knockdown experiment for circCSNK1G3 22.78
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 22.66
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 22.66
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 22.55
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 22.51
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 22.5
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 22.5
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 22.4
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 22.4
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 22.31
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 22.28
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 21.95
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 21.87
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 21.87
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 21.79
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 21.79
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 21.73
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 21.73
CHD1 regulates cell fate determination by activation of differentiation-induced genes 21.69
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 21.67
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 21.46
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 21.45
High level DNA repair gene expression in human ES cells 21.34
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 21.17
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 21.01
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 20.98
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 20.91
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 20.89
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 20.89
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 20.86
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 20.82
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 20.82
Molecular Mechanisms of Endothelial Hyperpermeability 20.77
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 20.72
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 20.55
RNA-seq of stable and unstable section of human atherosclerotic plaques 20.43
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 20.36
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 20.28
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 19.94
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 19.94
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 19.92
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 19.89
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 19.85
iPSC derived motor neuron cultures from C9ORF72 carriers 19.73
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 19.71
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 19.55
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 19.47
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 19.26
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 19.16
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 19.1
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 19.09
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 19.0
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 18.86
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 18.7
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 18.7
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 18.69
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 18.67
NRDE2 negatively regulates nuclear exosome functions 18.51
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 18.43
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 18.43
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 18.42
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 18.31
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 18.19
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 18.13
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 18.06
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 18.04
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 17.99
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 17.97
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 17.95
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 17.95
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 17.91
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 17.88
Identification of Atrial Fibrillation associated genes and functional non-coding variants 17.88
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 17.86
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 17.61
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 17.6
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 17.58
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 17.58
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 17.55
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 17.46
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 17.38
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 17.38
Electronic cigarettes 17.37
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 17.23
Differential gene expression of human melanoma cells [RNA-seq] 17.23
Splicing and epigenetic factors jointly regulate epidermal differentiation 17.23
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 17.15
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 17.15
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 17.11
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 17.1
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 17.06
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 16.85
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 16.8
Neurofibroma 16.72
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 16.72
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 16.53
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 16.52
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 16.49
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 16.35
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 16.35
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 16.31
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 16.31
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 16.29
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 16.26
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 16.21
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 16.13
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 16.13
Effect of mitochondria deficiency on senescence-associated gene expression 16.09
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 15.97
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 15.9
RNA-seq analysis of RALD iPSCs after in vitro differentiation 15.9
RNA-seq of MCF10A cells and CAF 15.89
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 15.86
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 15.86
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 15.81
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 15.71
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 15.71
Maturation of human iNSCs 15.51
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 15.45
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 15.43
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 15.34
G-quadruplex structures mark human regulatory chromatin 15.3
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 15.23
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 15.17
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 15.11
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 15.11
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 15.05
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 15.02
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 14.99
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 14.99
Transcriptomic and gene ontology profiling of the human corneal cell types 14.98
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 14.95
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 14.94
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 14.87
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 14.76
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 14.74
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 14.7
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 14.69
High-Throughput Kinetic Analysis of Fractional Killing 14.64
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 14.58
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 14.52
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 14.34
Human embryonic stem cells in E8 and AKIT culture medium 14.34
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 14.31
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 14.31
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 14.27
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 14.22
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 14.18
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 14.12
Effect of from Human Umbilical Vein Endothelial Cells 14.11
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 14.05
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 14.02
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 14.01
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 13.98
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 13.94
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 13.93
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 13.93
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 13.92
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 13.9
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 13.84
Identification of HOXB13 target genes responsive to BET inhibitors 13.84
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 13.81
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 13.59
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 13.53
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 13.5
Endothelial gene expression analysis 13.46
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 13.46
Paxillin regulates genomic networks in prostate cancer [PC3] 13.4
Lineage specific differentiation is influenced by state of human pluripotency 13.37
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 13.37
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 13.36
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 13.32
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 13.28
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 13.27
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 13.23
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 13.11
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 13.0
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 12.99
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 12.92
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 12.88
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 12.88
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 12.86
ARID1A and ARID1B loss in HCT116 and TOV21G cells 12.84
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 12.81
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 12.74
Modeling Familial Cancer with iPSC Approaches 12.71
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 12.67
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 12.61
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 12.61
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 12.61
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 12.59
Retinoic acid suppresses MYB in adenoid cystic carcinoma 12.59
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 12.59
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 12.53
hnRNP C is a key regulator of protein synthesis in mitosis 12.48
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 12.47
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 12.38
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 12.37
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 12.35
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 12.28
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 12.25
Mitochondrial dsRNA triggers antiviral signalling in humans 12.2
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 12.17
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 12.08
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 11.96
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 11.77
circRNA profile in hypopharyngeal cancer 11.75
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 11.7
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 11.68
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 11.67
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 11.55
Transcriptomic analysis of the HOTAIR-regulated genes 11.36
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 11.31
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 11.3
Disruption of GRIN2B impairs differentiation in human neurons 11.3
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 11.1
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 11.07
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 11.06
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 10.98
Noncoding regions are the main source of targetable tumor-specific antigens 10.95
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 10.88
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 10.83
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 10.83
Activity-dependent transcriptional changes in human neurons 10.82
CSL RNA-Seq on HKC and SCC cell lines 10.82
CSL 10.82
Postnatal lipids drive hepatocyte maturation 10.8
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 10.5
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 10.44
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 10.3
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 10.3
RNA seq comparison between scrambled and shGRP78 cells 10.29
Argonaute proteins couple chromatin silencing to alternative splicing 10.23
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 10.23
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 10.16
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 10.07
FGF2 regulation of gene expression in stable inducible Neurons 10.06
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 9.99
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 9.98
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 9.96
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 9.96
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 9.93
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 9.89
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 9.83
The effect of Abl kinases on non-small cell carcinoma global transcriptome 9.68
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 9.52
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 9.48
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 9.46
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 9.46
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 9.42
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 9.42
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 9.31
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 9.31
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 9.08
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 9.08
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 9.04
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 8.93
RNA-seq of naive and primed ES cells 8.79
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 8.76
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 8.73
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 8.64
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 8.55
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 8.55
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 8.44
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 8.29
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 8.2
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 8.01
RNA-seq analysis upon ARID1B overexpression 8.01
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 7.95
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 7.9
TGF-β regulation of miRNA expression in pancreatic cancer 7.84
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 7.83
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 7.81
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 7.79
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 7.67
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 7.67
SF3B1 Degron knockdown RNA-seq 7.66
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 7.55
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 7.55
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 7.5
RNA-seq analysis of gene expression patterns during hESC neural differentiation 7.44
hESC neural differentiation 7.44
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 7.38
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 7.26
PNET animal model: new insights (II) 7.12
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 7.01
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 7.01
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 7.0
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 7.0
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 6.99
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 6.9
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 6.88
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 6.62
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 6.44
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 6.42
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 6.34
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 6.3
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 6.29
Molecular Criteria for Defining the Naive Human Pluripotent State 6.26
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 6.15
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 6.13
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 6.1
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 6.04
The effect of insulin on mRNA transcription of human pluripotent stem cells 6.0
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 5.96
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 5.93
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 5.91
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 5.87
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 5.69
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 5.69
RNAseq in Alzheimer's Disease patients 5.5
mRNA sequencing of oropharyngeal cancer cell lines 5.45
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 5.44
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 5.37
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 5.35
The bromodomain protein BRD4 regulates splicing during heat shock 5.15
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 5.1
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 5.1
Genome-wide discovery of human splicing branchpoints [RNAse] 5.03
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 5.01
Regulatory network controlling tumor-promoting inflammation in human cancers 5.0
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 5.0
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 4.99
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 4.96
Genome-wide discovery of human splicing branchpoints 4.7
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 4.64
RNA splicing alteration on glioblastoma and normal neural stem cells 4.57
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 4.54
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 4.54
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 4.42
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 4.36
CDK4/6 inhibitor resistance in prostate cancer 4.24
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 4.18
UV_24h_GRO-Seq 4.07
Redifferentiation of expanded human islet β cells by inhibition of ARX 4.04
RNA expression analysis upon JMJD1C depletion 3.99
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 3.99
BASP1 modifies the Tamoxifen response 3.97
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 3.81
Gene expression analysis of human liver progenitor-like cells in culture 3.8
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 3.69
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 3.68
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 3.4
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 3.37
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 3.36
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 3.35
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 3.29
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 3.27
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 3.21
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 3.21
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 3.07
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 3.07
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 2.9
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 2.66
ML29755 RNA-seq data 2.51
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 2.49
RNA-sequencing in immortalized human mammary epithelial cells 2.4
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 2.4
MCF-7 as a model for functional analysis of breast cancer risk variants 2.24
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 2.23
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 2.23
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 2.23
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 2.23
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 2.21
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 2.21
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 2.06
nELAVL HITS-CLIP in Alzheimer's Disease patients 1.85
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 1.84
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 1.82
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 1.76
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 1.76
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 1.49
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 1.35
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 1.3
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 1.3
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 1.29
Dissecting neural differentiation regulatory networks through epigenetic footprinting 1.12
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 1.03
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 1.03
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 1.0
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 1.0
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 0.86
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.71
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 0.66
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 0.65
Microprocessor mediates transcription termination in long noncoding microRNA genes 0.57
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.54
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.45
RNA sequencing of human pancreatic cancer cell lines 0.45
RNAseq of Breast cancer PDX samples 0.38
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 0.31
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 0.28
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.14
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.14
Leucegene: AML sequencing (part 6) 0.11
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.08
Global transcriptome analysis of WT versus HEB-/- hESCs 0.04
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 0.04
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 0.0
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation